Furthermore, no evidence for any association between these variants in MMR genes and breast cancer has been seen in larger case control studies [ 1 ], segregation analysis [ 23 ], nor in prospective analysis of PV carriers [ 24 ], with the possible exception of MSH6 in BRIDGES, which was borderline significant at two-fold risk [ 16 ].
← all excerpts
Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior <i>BRCA1/2</i> Probability.
1
—
—